Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the role of cholinergic degeneration in cognitive fluctuations in Lewy body dementias; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Dementia With Lewy Bodies, Parkinson Disease Dementia | Phase 4 | Status: RECRUITING